INHIBRx
- Biotech or pharma, therapeutic R&D
Inhibrx is a clinical-stage biotech company that has leveraged its protein-engineering expertise and a proprietary single-domain antibody platform to build a unique and varied pipeline of novel therapeutic candidates.